Blue Jet Healthcare Limited (NSE:BLUEJET)

India · Delayed Price · Currency is INR

542.00

+3.95 (0.73%)

Oct 1, 2026, 3:29 PM IST

Market Cap	102.55B -6.2%
Revenue (ttm)	8.86B -27.5%
Net Income	2.35B -34.5%
EPS	13.54 -34.5%
Shares Out	189.28M
PE Ratio	40.02
Forward PE	30.85
Dividend	1.20 (0.22%)
Ex-Dividend Date	Sep 11, 2026

Volume	522,532
Open	538.05
Previous Close	538.05
Day's Range	521.15 - 545.00
52-Week Range	325.00 - 692.90
Beta	0.62
Analysts	Buy
Price Target	568.00 (+4.8%)
Est. Earnings	Nov 4, 2026

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of artificial sweeteners, pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in products. It provides contrast media intermediates, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related supplies to healthcare, pharma, animal feed, and food and beverages industries. It has operations in India, Norway... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1968

Employees 581

Stock Exchange National Stock Exchange of India

Ticker Symbol BLUEJET

Full Company Profile

Financial Performance

In fiscal year 2026, Blue Jet Healthcare's revenue was 9.47 billion, a decrease of -8.03% compared to the previous year's 10.30 billion. Earnings were 2.48 billion, a decrease of -18.80%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for BLUEJET stock is "Buy." The 12-month stock price target is ₹568.00, which is an increase of 4.80% from the latest price.

Price Target

₹568.00

(4.80% upside)

Analyst Consensus: Buy

Stock Forecasts